<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:38:31Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:2964648" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:2964648</identifier><datestamp>2010-10-28</datestamp><setSpec>bmcneul</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Neurol</journal-id>
      <journal-title-group>
        <journal-title>BMC Neurology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2377</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC2964648</article-id>
      <article-id pub-id-type="pmcid">PMC2964648</article-id>
      <article-id pub-id-type="pmc-uid">2964648</article-id>
      <article-id pub-id-type="pmid">20932283</article-id>
      <article-id pub-id-type="publisher-id">1471-2377-10-89</article-id>
      <article-id pub-id-type="pmid">20932283</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2377-10-89</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Mutational spectrum of the <italic>SPG4 </italic>(<italic>SPAST</italic>) and <italic>SPG3A </italic>(<italic>ATL1</italic>) genes in Spanish patients with hereditary spastic paraplegia</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes" id="A1">
          <name>
            <surname>Ãlvarez</surname>
            <given-names>Victoria</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>victoria.alvarez@sespa.princast.es</email>
        </contrib>
        <contrib contrib-type="author" id="A2">
          <name>
            <surname>SÃ¡nchez-Ferrero</surname>
            <given-names>Elena</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>tohelli@hotmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A3">
          <name>
            <surname>Beetz</surname>
            <given-names>Christian</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>Christian.Beetz@med.uni-jena.de</email>
        </contrib>
        <contrib contrib-type="author" id="A4">
          <name>
            <surname>DÃ­az</surname>
            <given-names>Marta</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>martaediaz@yahoo.es</email>
        </contrib>
        <contrib contrib-type="author" id="A5">
          <name>
            <surname>Alonso</surname>
            <given-names>BelÃ©n</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>belen.montanel@hotmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A6">
          <name>
            <surname>Corao</surname>
            <given-names>Ana I</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>anacora@hotmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A7">
          <name>
            <surname>GÃ¡mez</surname>
            <given-names>Josep</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>pepgamez@gmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A8">
          <name>
            <surname>Esteban</surname>
            <given-names>JesÃºs</given-names>
          </name>
          <xref ref-type="aff" rid="I4">4</xref>
          <email>jesteban.hdoc@salud.madrid.org</email>
        </contrib>
        <contrib contrib-type="author" id="A9">
          <name>
            <surname>Gonzalo</surname>
            <given-names>Juan F</given-names>
          </name>
          <xref ref-type="aff" rid="I4">4</xref>
          <email>juanchogonzalo@yahoo.es</email>
        </contrib>
        <contrib contrib-type="author" id="A10">
          <name>
            <surname>Pascual-Pascual</surname>
            <given-names>Samuel I</given-names>
          </name>
          <xref ref-type="aff" rid="I5">5</xref>
          <email>ipascualp.hulp@salud.madrid.org</email>
        </contrib>
        <contrib contrib-type="author" id="A11">
          <name>
            <surname>de Munain</surname>
            <given-names>Adolfo LÃ³pez</given-names>
          </name>
          <xref ref-type="aff" rid="I6">6</xref>
          <email>ADOLFO.LOPEZDEMUNAINARREGUI@osakidetza.net</email>
        </contrib>
        <contrib contrib-type="author" id="A12">
          <name>
            <surname>Moris</surname>
            <given-names>GermÃ¡n</given-names>
          </name>
          <xref ref-type="aff" rid="I7">7</xref>
          <email>gmorist@gmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A13">
          <name>
            <surname>Ribacoba</surname>
            <given-names>Renne</given-names>
          </name>
          <xref ref-type="aff" rid="I8">8</xref>
          <email>rribacoba@gmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A14">
          <name>
            <surname>MÃ¡rquez</surname>
            <given-names>Celedonio</given-names>
          </name>
          <xref ref-type="aff" rid="I9">9</xref>
          <email>celedoniomarquez@gmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A15">
          <name>
            <surname>Rosell</surname>
            <given-names>Jordi</given-names>
          </name>
          <xref ref-type="aff" rid="I10">10</xref>
          <email>jordi.rosell@ssib.es</email>
        </contrib>
        <contrib contrib-type="author" id="A16">
          <name>
            <surname>MarÃ­n</surname>
            <given-names>Rosario</given-names>
          </name>
          <xref ref-type="aff" rid="I11">11</xref>
          <email>MAJESUS.GARCIABARCINA@osakidetza.net</email>
        </contrib>
        <contrib contrib-type="author" id="A17">
          <name>
            <surname>GarcÃ­a-Barcina</surname>
            <given-names>Maria J</given-names>
          </name>
          <xref ref-type="aff" rid="I12">12</xref>
          <email>genetica.hpm.sspa@juntadeandalucia.es</email>
        </contrib>
        <contrib contrib-type="author" id="A18">
          <name>
            <surname>del Castillo</surname>
            <given-names>Emilia</given-names>
          </name>
          <xref ref-type="aff" rid="I13">13</xref>
          <email>genemalaga.hch.sspa@juntadeandalucia.es</email>
        </contrib>
        <contrib contrib-type="author" id="A19">
          <name>
            <surname>Benito</surname>
            <given-names>Carmen</given-names>
          </name>
          <xref ref-type="aff" rid="I13">13</xref>
          <email>victoriaalvaremartinez@yahoo.es</email>
        </contrib>
        <contrib contrib-type="author" id="A20">
          <name>
            <surname>Coto</surname>
            <given-names>Eliecer</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>eliecer.coto@sespa.princast.es</email>
        </contrib>
        <on-behalf-of>the group for the study of the genetics of Spastic Paraplegia* victoria.alvarez@sespa.princast.es</on-behalf-of>
      </contrib-group>
      <aff id="I1"><label>1</label>Laboratory of Molecular Genetics -Genetic Unit, Hospital Universitario Central de Asturias, Oviedo, Spain</aff>
      <aff id="I2"><label>2</label>Institute for Clinical Chemistry and Laboratory Medicine, University Hospital Jena, Jena, Germany</aff>
      <aff id="I3"><label>3</label>Neurology Department, Hospital Universitari Vall d'Hebron. Univ. Autonoma Barcelona, Spain</aff>
      <aff id="I4"><label>4</label>Neurology Department, Hospital 12 de Octubre, Madrid, Spain</aff>
      <aff id="I5"><label>5</label>Pediatric Neurology Department, University Hospital La Paz, Madrid, Spain</aff>
      <aff id="I6"><label>6</label>Neurology Department, Hospital Donostia-Instituto Biodonostia-Ciberned, San SebastiÃ¡n, Spain</aff>
      <aff id="I7"><label>7</label>Neurology Department, Hospital San AgustÃ­n, Aviles, Spain</aff>
      <aff id="I8"><label>8</label>Neurology Department, Hospital Alvarez-Buylla, Mieres, Spain</aff>
      <aff id="I9"><label>9</label>Neurology Department, Hospital Universitario Virgen del Rocio, Sevilla, Spain</aff>
      <aff id="I10"><label>10</label>Department of Genetics, Hospital Universitari Son Dureta, Palma de Mallorca, Spain</aff>
      <aff id="I11"><label>11</label>HGenetics Unit, Hospital Universitario Puerta del Mar, CÃ¡diz, Spain</aff>
      <aff id="I12"><label>12</label>Genetics Department, Hospital de Basurto, Bilbao, Spain</aff>
      <aff id="I13"><label>13</label>Genetics Unit, Hospital Universitario Carlos Haya, MÃ¡laga, Spain</aff>
      <pub-date pub-type="collection">
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>8</day>
        <month>10</month>
        <year>2010</year>
      </pub-date>
      <volume>10</volume>
      <fpage>89</fpage>
      <lpage>89</lpage>
      <history>
        <date date-type="received">
          <day>9</day>
          <month>6</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>8</day>
          <month>10</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright Â©2010 Ãlvarez et al; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2010</copyright-year>
        <copyright-holder>Ãlvarez et al; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.biomedcentral.com/1471-2377/10/89"/>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Hereditary Spastic Paraplegias (HSP) are characterized by progressive spasticity and weakness of the lower limbs. At least 45 loci have been identified in families with autosomal dominant (AD), autosomal recessive (AR), or X-linked hereditary patterns. Mutations in the <italic>SPAST </italic>(<italic>SPG4</italic>) and <italic>ATL1 </italic>(<italic>SPG3A</italic>) genes would account for about 50% of the ADHSP cases.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>We defined the <italic>SPAST </italic>and <italic>ATL1 </italic>mutational spectrum in a total of 370 unrelated HSP index cases from Spain (83% with a pure phenotype).</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>We found 50 <italic>SPAST </italic>mutations (including two large deletions) in 54 patients and 7 <italic>ATL1 </italic>mutations in 11 patients. A total of 33 of the <italic>SPAST </italic>and 3 of the <italic>ATL1 </italic>were new mutations. A total of 141 (31%) were familial cases, and we found a higher frequency of mutation carriers among these compared to apparently sporadic cases (38% vs. 5%). Five of the <italic>SPAST </italic>mutations were predicted to affect the pre-mRNA splicing, and in 4 of them we demonstrated this effect at the cDNA level. In addition to large deletions, splicing, frameshifting, and missense mutations, we also found a nucleotide change in the stop codon that would result in a larger ORF.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>In a large cohort of Spanish patients with spastic paraplegia, <italic>SPAST </italic>and <italic>ATL1 </italic>mutations were found in 15% of the cases. These mutations were more frequent in familial cases (compared to sporadic), and were associated with heterogeneous clinical manifestations.</p>
        </sec>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>The hereditary spastic paraplegias (HSP) are characterized by progressive spasticity and weakness of the lower limbs due to axonal degeneration in the pyramidal tract. The disease is classified as "pure" when spasticity is the only clinical finding, and as "complicated" when other clinical features (dementia, cerebellar ataxia, epilepsy, peripheral neuropathy) are also present [<xref ref-type="bibr" rid="B1">1</xref>]. HSP is frequently familial and at least 45 loci have been identified in families with autosomal dominant (AD), autosomal recessive (AR), or X-linked inheritance [<xref ref-type="bibr" rid="B2">2</xref>-<xref ref-type="bibr" rid="B4">4</xref>]. This genetic heterogeneity partly explains the differences in disease severity, age at onset, rate of progression, and degree of disability between families. However, intrafamilial heterogeneity is also frequent.</p>
      <p>SPG4 (OMIM#604277) is the most common form of HSP, accounting for approximately 40% of the familial and 6-15% of the sporadic cases. The <italic>SPAST</italic>/<italic>SPG4 </italic>gene encodes spastin, a member of the AAA (ATPase associated with various cellular activities) family of proteins, implicated in the remodeling of protein complexes upon ATP hydrolysis and the coordination of axonal microtubule interactions with the tubular endoplasmic reticulum network [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>]. To date, &gt;240 <italic>SPAST </italic>mutations have been reported (<ext-link ext-link-type="uri" xlink:href="http://www.hgmd.cf.ac.uk/ac/index.php">http://www.hgmd.cf.ac.uk/ac/index.php</ext-link>; date of consultation August 2, 2010), mainly in patients with pure HSP [<xref ref-type="bibr" rid="B7">7</xref>-<xref ref-type="bibr" rid="B12">12</xref>]. Most of the <italic>SPAST </italic>mutations are single-nucleotide changes or small deletions/insertions, but large deletions and duplications have also been reported [<xref ref-type="bibr" rid="B13">13</xref>-<xref ref-type="bibr" rid="B16">16</xref>]. This suggested that both, haploinsufficiency and "toxic" gain of function could explain the pathogenic mechanism of <italic>SPAST </italic>mutations [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B17">17</xref>-<xref ref-type="bibr" rid="B19">19</xref>].</p>
      <p>SPG3A (OMIM#606439) is the second most frequent form of ADHSP. The <italic>ATL1/SPG3A </italic>gene encodes atlastin, a protein localized in the endoplasmic reticulum and the Golgi and implicated in vesicle trafficking and neurite outgrowth [<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref>]. To date, &gt;25 <italic>ATL1 </italic>mutations have been reported (<ext-link ext-link-type="uri" xlink:href="http://www.hgmd.cf.ac.uk/ac/index.php">http://www.hgmd.cf.ac.uk/ac/index.php</ext-link>; date of consultation August 2, 2010), mainly missense changes that supported a gain of function pathogenic mechanism. <italic>ATL1 </italic>mutations accounted for approximately 10% of the ADHSP families, and have been mainly found in pure HSP [<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B23">23</xref>]. <italic>ATL1 </italic>mutations are also frequent in early onset (childhood or adolescence) cases [<xref ref-type="bibr" rid="B24">24</xref>-<xref ref-type="bibr" rid="B26">26</xref>].</p>
      <p>This is the first report of the mutational spectrum of the <italic>SPAST </italic>and <italic>ATL1 </italic>genes in a large cohort of unrelated HSP patients from Spain. Few studies on cohorts &gt;200 patients have been published, and the parallel screening of both genes was rarely reported.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <sec>
        <title>Patients</title>
        <p>This study was approved by the Ethical Committee of Hospital Universitario Central Asturias (HUCA), and all the participants (patients and controls) signed an informed consent. A total of 370 non-related patients (index cases) were recruited through the Neurology Departments of several Hospitals from Spain. HSP was diagnosed by qualified neurologists on the basis of Harding's criteria. Based on the clinical, radiological, and biochemical findings, cases with diseases that mimicked spastic paraplegia were excluded [<xref ref-type="bibr" rid="B27">27</xref>]. A total of 141 patients (38%) had a family history of HSP with a dominant inheritance pattern, and were thus classified as ADHSP cases. The absence of family history of the disease was established in 229 patients (62%) after interview on their first and second degree relatives. These cases were classified as "apparently" sporadic or with an uncertain inheritance pattern. In 177 of these the two parents were alive and did not have symptoms consistent with HSP, while in 52 the inheritance pattern could not be established because no clinical data were available from relatives.</p>
      </sec>
      <sec>
        <title><italic>SPAST </italic>and <italic>ATL1 </italic>sequencing</title>
        <p>DNA was obtained from blood leukocytes and the 17 coding exons of <italic>SPAST </italic>(plus at least 50 bp of the flanking intronic sequences) were polymerase chain reaction (PCR) amplified (Additional file <xref ref-type="supplementary-material" rid="S1">1</xref>, Table S1). PCR fragments were purified and the two strands were sequenced using Big Dye chemistry in an ABI3130 system (Applied Biosystems, Ca, USA). These sequences were compared with the <italic>SPAST </italic>reference sequence (ENSG00000021574 for the genomic; ENST00000315285 for the transcript; <ext-link ext-link-type="uri" xlink:href="http://www.ensembl.org">http://www.ensembl.org</ext-link>). In patients who were negative for <italic>SPAST </italic>mutations and had ADHSP (n = 88) or patients without a family history of HSP and onset age â¤20 years (n = 99), we amplified and sequenced the 13 coding exons of <italic>ATL1 </italic>(reference sequences ENSG00000198513 for the genomic, and ENST00000358385 for the transcript; <ext-link ext-link-type="uri" xlink:href="http://www.ensembl.org">http://www.ensembl.org</ext-link>). All the DNA sequence variants were named following the guidelines of the Human Genome Variation Society (<ext-link ext-link-type="uri" xlink:href="http://www.hgvs.org/mutnomen">http://www.hgvs.org/mutnomen</ext-link>).</p>
      </sec>
      <sec>
        <title>Controls screening</title>
        <p>All the new putative mutations (not previously reported as <italic>SPAST </italic>or <italic>ATL1 </italic>mutations or polymorphisms) were screened in 400 controls. These were healthy individuals aged 21-65 years recruited through the Blood Bank of HUCA. The new nucleotide changes were genotyped through PCR-RFLP, single strand conformation analysis (SSCA), or denaturing high performance liquid chromatography (DHPLC), as reported [<xref ref-type="bibr" rid="B28">28</xref>]. Each PCR fragment containing a putative mutation gave a characteristic RFLP, SSCA or DHPLC pattern, and we could thus determine its presence/absence in the controls. When a new nucleotide change was not found among the 400 controls we determined, when it was possible, the carrier status of all the available affected relatives to confirm the segregation of the mutation with the disease.</p>
      </sec>
      <sec>
        <title>MLPA analysis</title>
        <p>The multiplex ligation dependent probe amplification (MLPA) assay with the Salsa Kit P165 HPA (MRC Holland, Amsterdam) was used to determine the existence of genome copy number aberrations in the <italic>SPAST </italic>and <italic>ATL1 </italic>genes in ADHSP patients who were negative for sequencing mutations [<xref ref-type="bibr" rid="B13">13</xref>]. To investigate the consequences of large <italic>SPAST </italic>deletions at the transcript level, we isolated the mRNA from leukocytes in 10 ml of blood (Trizol reagent, Invitrogen, Carlsbad, CA, USA) and synthesised the cDNA (Quantitec Reverse Transcripcion kit, Quiagen, Hilden, Germany). The cDNA was amplified with primers that matched exons flanking the deletion (conditions available upon request), and the PCR products were purified and sequenced.</p>
      </sec>
      <sec>
        <title>Analysis of <italic>SPAST </italic>transcripts</title>
        <p>To determine the effect of some <italic>SPAST </italic>mutations on mRNA transcripts, the cDNA synthesised from leukocytes was amplified with primers that matched the exons flanking the mutation (additional file <xref ref-type="supplementary-material" rid="S1">1</xref>, Table S2), and the PCR fragments were purified from agarose gels and sequenced.</p>
      </sec>
      <sec>
        <title>Statistical analysis</title>
        <p>The analysis of variance (SPSS 17.0 software) was used to compare the mean onset age and disease duration between patients with mutations in <italic>SPAST </italic>and <italic>ATL1 </italic>and patients without mutations.</p>
      </sec>
    </sec>
    <sec>
      <title>Results</title>
      <sec>
        <title>Patients characteristics</title>
        <p>We studied a total of 370 unrelated HSP index cases, with a mean onset age of 28 (Â± 21) years (range 1-77 years), and a mean disease duration of 17 (Â± 15) years. A total of 321 patients (87%) had a pure HSP, while 49 (13%) were complicated cases with peripheral neuropathy (the most frequent finding), cerebellar or cerebral atrophy, mental retardation, nystagmus, or dysarthia.</p>
        <p>A total of 44 of the 141 patients (31%) with ADHSP had a <italic>SPAST </italic>mutation, and 10 mutations were found among the 229 (5%) cases apparently sporadic or with an uncertain inheritance pattern. However, in three of these patients the mutation (p.Leu426Val, p.Lys503insArg, and p.Met390Val) was <italic>de novo </italic>because none of the two parents was mutation carrier (the paternity was confirmed). We found 10 <italic>ATL1 </italic>mutation carriers among 88 ADHSP cases (11%), and the only apparently sporadic proband had a <italic>de novo </italic>mutation (p.Gln154Glu) (Additional file <xref ref-type="supplementary-material" rid="S2">2</xref>, Figure S1).</p>
      </sec>
      <sec>
        <title><italic>SPAST </italic>mutations</title>
        <p>We found 48 <italic>SPAST </italic>mutations in 52 patients (Table <xref ref-type="table" rid="T1">1</xref>). These were missense changes in amino acids conserved between species (n = 22), nonsense mutations (n = 7), small frameshifting insertions/deletions (n = 13), nucleotide changes in the intronic splicing consensus sequence (n = 5), and a sense mutation in the stop codon (Figure <xref ref-type="fig" rid="F1">1</xref>). A total of 15 mutations had been previously reported, while 33 (69%) were novel.</p>
        <table-wrap id="T1" position="float">
          <label>Table 1</label>
          <caption>
            <p>Mutations identied in the <italic>SPAST </italic>gene in the Spanish HSP cohort.</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th align="center">Case</th>
                <th align="center">Onset age (Years)</th>
                <th align="center">Phenotype*</th>
                <th align="center">GENE</th>
                <th align="center">EXÃN</th>
                <th align="center">Mutation</th>
                <th align="center">Protein change</th>
                <th align="center">Reference</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="center">193</td>
                <td align="center">60</td>
                <td align="center">Pure-UHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">1</td>
                <td align="center">c.349C-&gt;T</td>
                <td align="center">p.Arg117X</td>
                <td align="center">This study</td>
              </tr>
              <tr>
                <td align="center">69</td>
                <td align="center">45</td>
                <td align="center">Pure-SHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">2</td>
                <td align="center">c.469delG</td>
                <td align="center">p.Glu157f sX159</td>
                <td align="center">This study</td>
              </tr>
              <tr>
                <td align="center">81</td>
                <td align="center">35</td>
                <td align="center">Pure-SHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">3</td>
                <td align="center">c.577C&gt;T</td>
                <td align="center">p.Gln193X</td>
                <td align="center">[<xref ref-type="bibr" rid="B7">7</xref>]</td>
              </tr>
              <tr>
                <td align="center">138</td>
                <td align="center">2</td>
                <td align="center">Complicated-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">3</td>
                <td align="center">c.583C-&gt;G</td>
                <td align="center">p.Leu195Val</td>
                <td align="center">[<xref ref-type="bibr" rid="B10">10</xref>]</td>
              </tr>
              <tr>
                <td align="center">166</td>
                <td align="center">43</td>
                <td align="center">Pure-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">5</td>
                <td align="center">C.782C&gt;G</td>
                <td align="center">p.Ser261X</td>
                <td align="center">[<xref ref-type="bibr" rid="B7">7</xref>]</td>
              </tr>
              <tr>
                <td align="center">197</td>
                <td align="center">53</td>
                <td align="center">Pure-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">5</td>
                <td align="center">c.857-859delCTA</td>
                <td align="center">p.Pro286-Thr287delinsP</td>
                <td align="center">This study</td>
              </tr>
              <tr>
                <td align="center">257</td>
                <td align="center">23</td>
                <td align="center">Pure-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">5</td>
                <td align="center">c.806c-&gt;G</td>
                <td align="center">Tyr269X</td>
                <td align="center">[<xref ref-type="bibr" rid="B7">7</xref>]</td>
              </tr>
              <tr>
                <td align="center">300</td>
                <td align="center">8</td>
                <td align="center">Pure-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">5</td>
                <td align="center">c.746C&gt;G</td>
                <td align="center">p.Ser249X</td>
                <td align="center">[<xref ref-type="bibr" rid="B8">8</xref>]</td>
              </tr>
              <tr>
                <td/>
                <td/>
                <td/>
                <td/>
                <td/>
                <td/>
                <td/>
                <td/>
              </tr>
              <tr>
                <td align="center">174</td>
                <td align="center">1</td>
                <td align="center">Pure-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">6</td>
                <td align="center">c.879delG</td>
                <td align="center">p. Pro293fsX314</td>
                <td align="center">This study</td>
              </tr>
              <tr>
                <td align="center">205</td>
                <td align="center">20</td>
                <td align="center">Pure-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">6</td>
                <td align="center">.936-37insA</td>
                <td align="center">pLys.312fsX318</td>
                <td align="center">This study</td>
              </tr>
              <tr>
                <td align="center">206</td>
                <td align="center">30</td>
                <td align="center">Pure- UHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">6</td>
                <td align="center">c.977-978insA</td>
                <td align="center">p.Asn326fsX331</td>
                <td align="center">This study</td>
              </tr>
              <tr>
                <td/>
                <td/>
                <td/>
                <td/>
                <td/>
                <td/>
                <td/>
                <td/>
              </tr>
              <tr>
                <td align="center">335</td>
                <td align="center">32</td>
                <td align="center">Pure- SHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">6</td>
                <td align="center">c.878C&gt;T</td>
                <td align="center">p.Pro293Leu</td>
                <td align="center">This study</td>
              </tr>
              <tr>
                <td align="center">13</td>
                <td align="center">40</td>
                <td align="center">Pure-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">7</td>
                <td align="center">c.1040A&gt;C</td>
                <td align="center">p.Gln347His</td>
                <td align="center">This study</td>
              </tr>
              <tr>
                <td align="center">130</td>
                <td align="center">0</td>
                <td align="center">Complicated-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">7</td>
                <td align="center">c.1082C&gt;T</td>
                <td align="center">p.Pro361Leu</td>
                <td align="center">[<xref ref-type="bibr" rid="B41">41</xref>]</td>
              </tr>
              <tr>
                <td align="center">133</td>
                <td align="center">35</td>
                <td align="center">Pure-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">7</td>
                <td align="center">c.1054C&gt;T</td>
                <td align="center">p.Gln352X</td>
                <td align="center">This study</td>
              </tr>
              <tr>
                <td align="center">351</td>
                <td/>
                <td align="center">Pure-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">7</td>
                <td align="center">c. 1091-1098delGGCCTGAG</td>
                <td align="center">p.Arg364fsX392</td>
                <td align="center">This study</td>
              </tr>
              <tr>
                <td align="center">47</td>
                <td align="center">66</td>
                <td align="center">Pure-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">8</td>
                <td align="center">c.1139T&gt;A</td>
                <td align="center">p.Leu380His</td>
                <td align="center">[<xref ref-type="bibr" rid="B15">15</xref>]</td>
              </tr>
              <tr>
                <td align="center">111</td>
                <td align="center">49</td>
                <td align="center">Pure-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">8</td>
                <td align="center">c.1133T-&gt;G</td>
                <td align="center">p.Leu378Arg</td>
                <td align="center">This study</td>
              </tr>
              <tr>
                <td align="center">180</td>
                <td align="center">54</td>
                <td align="center">Pure-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">8</td>
                <td align="center">c.1172T&gt;C</td>
                <td align="center">p.Leu391Pro</td>
                <td align="center">[<xref ref-type="bibr" rid="B42">42</xref>]</td>
              </tr>
              <tr>
                <td align="center">273</td>
                <td align="center">1</td>
                <td align="center">Complicated-SHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">8</td>
                <td align="center">c.1168A-&gt;G</td>
                <td align="center">p.Met390Val</td>
                <td align="center">[<xref ref-type="bibr" rid="B43">43</xref>]</td>
              </tr>
              <tr>
                <td align="center">7</td>
                <td align="center">44</td>
                <td align="center">Pure-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">9</td>
                <td align="center">c.1215-1219delTATAA</td>
                <td align="center">p. Asn405fsX441</td>
                <td align="center">[<xref ref-type="bibr" rid="B7">7</xref>]</td>
              </tr>
              <tr>
                <td align="center">22</td>
                <td align="center">42</td>
                <td align="center">Pure-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">9</td>
                <td align="center">c.1174-1180delGCTAAG</td>
                <td align="center">p.Ala392fsX405</td>
                <td align="center">This study</td>
              </tr>
              <tr>
                <td align="center">23</td>
                <td align="center">35</td>
                <td align="center">Pure-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">9</td>
                <td align="center">c.1226G&gt;A</td>
                <td align="center">p.Ala409Thr</td>
                <td align="center">This study</td>
              </tr>
              <tr>
                <td align="center">32</td>
                <td align="center">35</td>
                <td align="center">Pure-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">9</td>
                <td align="center">c.1177-1180delAAAGCAGTA GCT</td>
                <td align="center">p.Lys393-Ala396del</td>
                <td align="center">This study</td>
              </tr>
              <tr>
                <td align="center">52</td>
                <td align="center">45</td>
                <td align="center">Pure-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">9</td>
                <td align="center">c.1210-1212delTTT</td>
                <td align="center">p.Phe404del</td>
                <td align="center">[<xref ref-type="bibr" rid="B44">44</xref>]</td>
              </tr>
              <tr>
                <td align="center">80</td>
                <td align="center">38</td>
                <td align="center">Pure-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">9</td>
                <td align="center">c.1210-1212delTTT</td>
                <td align="center">p.Phe404del</td>
                <td align="center">[<xref ref-type="bibr" rid="B44">44</xref>]</td>
              </tr>
              <tr>
                <td align="center">98</td>
                <td align="center">29</td>
                <td align="center">Pure-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">9</td>
                <td align="center">c.1192-93delGA/insT</td>
                <td align="center">Glu398fsX406</td>
                <td align="center">This study</td>
              </tr>
              <tr>
                <td align="center">179</td>
                <td align="center">10</td>
                <td align="center">Pure-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">9</td>
                <td align="center">c.1192-93delGA/insT</td>
                <td align="center">Glu398fsX406</td>
                <td align="center">This study</td>
              </tr>
              <tr>
                <td align="center">363</td>
                <td align="center">2</td>
                <td align="center">Pure_ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">9</td>
                <td align="center">C.1128A&gt;C</td>
                <td align="center">p.Ser410Arg</td>
                <td align="center">This study</td>
              </tr>
              <tr>
                <td align="center">135</td>
                <td align="center">47</td>
                <td align="center">Pure-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">10</td>
                <td align="center">c.1306T&gt;C</td>
                <td align="center">p.Ser436Pro</td>
                <td align="center">This study</td>
              </tr>
              <tr>
                <td align="center">170</td>
                <td align="center">3</td>
                <td align="center">Complicated-SHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">10</td>
                <td align="center">c.1276 C&gt;G</td>
                <td align="center">p.Leu426Val</td>
                <td align="center">[<xref ref-type="bibr" rid="B7">7</xref>]</td>
              </tr>
              <tr>
                <td align="center">373</td>
                <td align="center">10</td>
                <td align="center">Pure-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">10</td>
                <td align="center">c. 1321G-&gt;A</td>
                <td align="center">p.Asp441Asn</td>
                <td align="center">This study</td>
              </tr>
              <tr>
                <td align="center">50</td>
                <td align="center">2</td>
                <td align="center">Pure-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">11</td>
                <td align="center">c.1387A&gt;G</td>
                <td align="center">p.Thr463Ala</td>
                <td align="center">This study</td>
              </tr>
              <tr>
                <td align="center">200</td>
                <td align="center">35</td>
                <td align="center">Pure-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">11</td>
                <td align="center">c.1378c&gt;A</td>
                <td align="center">p.Arg460Ser</td>
                <td align="center">[<xref ref-type="bibr" rid="B45">45</xref>]</td>
              </tr>
              <tr>
                <td align="center">308</td>
                <td align="center">30</td>
                <td align="center">Pure -ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">IVS11</td>
                <td align="center">c.1414-2A&gt;C</td>
                <td align="center">Exon 12 skipping</td>
                <td align="center">This study</td>
              </tr>
              <tr>
                <td align="center">322</td>
                <td align="center">30</td>
                <td align="center">Pure_ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">IVS11</td>
                <td align="center">c.1414-1G&gt;C</td>
                <td align="center">Exon 12 skipping</td>
                <td align="center">This study</td>
              </tr>
              <tr>
                <td align="center">86</td>
                <td align="center">40</td>
                <td align="center">Pure- ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">12</td>
                <td align="center">c.1439-1145delTACTTGT/insC</td>
                <td align="center">p.Val480fs</td>
                <td align="center">This study</td>
              </tr>
              <tr>
                <td align="center">118</td>
                <td align="center">61</td>
                <td align="center">Pure-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">12</td>
                <td align="center">c.1466C-&gt; T</td>
                <td align="center">p.Pro489Leu</td>
                <td align="center">[<xref ref-type="bibr" rid="B46">46</xref>]</td>
              </tr>
              <tr>
                <td align="center">177</td>
                <td align="center">20</td>
                <td align="center">Pure-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">12</td>
                <td align="center">c.1492A&lt;G</td>
                <td align="center">p.Arg498Gly</td>
                <td align="center">This study</td>
              </tr>
              <tr>
                <td align="center">352</td>
                <td/>
                <td align="center">Pure-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">12</td>
                <td align="center">c.1474C&gt;T</td>
                <td align="center">p.Leu492Phe</td>
                <td align="center">This study</td>
              </tr>
              <tr>
                <td align="center">145</td>
                <td align="center">16</td>
                <td align="center">Pure-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">IVS12</td>
                <td align="center">c1494-2A&gt;G</td>
                <td align="center">presumed missplicing</td>
                <td align="center">This study</td>
              </tr>
              <tr>
                <td align="center">178</td>
                <td align="center">1</td>
                <td align="center">Pure-SHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">13</td>
                <td align="center">c.1507-1508insGGC</td>
                <td align="center">p.Lys503insArg</td>
                <td align="center">This study</td>
              </tr>
              <tr>
                <td align="center">334</td>
                <td align="center">32</td>
                <td align="center">Pure-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">13</td>
                <td align="center">c.1540A&gt;G</td>
                <td align="center">p.Arg503Trp</td>
                <td align="center">[<xref ref-type="bibr" rid="B11">11</xref>]</td>
              </tr>
              <tr>
                <td align="center">358</td>
                <td align="center">30</td>
                <td align="center">Pure-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">14</td>
                <td align="center">c.1540A&gt;G</td>
                <td align="center">p.Arg514Gly</td>
                <td align="center">[<xref ref-type="bibr" rid="B12">12</xref>]</td>
              </tr>
              <tr>
                <td align="center">253</td>
                <td align="center">18</td>
                <td align="center">Pure-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">15</td>
                <td align="center">c.1684C&gt;T</td>
                <td align="center">p.Arg562X</td>
                <td align="center">[<xref ref-type="bibr" rid="B7">7</xref>]</td>
              </tr>
              <tr>
                <td align="center">261</td>
                <td align="center">50</td>
                <td align="center">Pure-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">IVS15</td>
                <td align="center">c.1687+1G/A</td>
                <td align="center">Ex15 skipping</td>
                <td align="center">[<xref ref-type="bibr" rid="B7">7</xref>]</td>
              </tr>
              <tr>
                <td align="center">62</td>
                <td align="center">40</td>
                <td align="center">Pure-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">IVS15</td>
                <td align="center">c.1687+1G/T</td>
                <td align="center">Ex15 skipping</td>
                <td align="center">This study</td>
              </tr>
              <tr>
                <td align="center">103</td>
                <td align="center">40</td>
                <td align="center">Pure-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">17</td>
                <td align="center">c.1793T-&gt; C</td>
                <td align="center">p.Ile580Thr</td>
                <td align="center">This study</td>
              </tr>
              <tr>
                <td align="center">112</td>
                <td align="center">56</td>
                <td align="center">Pure-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">17</td>
                <td align="center">C.1739T-&gt; C</td>
                <td align="center">p.Ile580Thr</td>
                <td align="center">This study</td>
              </tr>
              <tr>
                <td align="center">212</td>
                <td align="center">35</td>
                <td align="center">Pure-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">17</td>
                <td align="center">c.1849T-&gt; G</td>
                <td align="center">p.X617Glu</td>
                <td align="center">This study</td>
              </tr>
              <tr>
                <td align="center">286</td>
                <td align="center">54</td>
                <td align="center">Complicated-UHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">17</td>
                <td align="center">c.1849T-&gt; G</td>
                <td align="center">p.X617Glu</td>
                <td align="center">This study</td>
              </tr>
              <tr>
                <td align="center">310</td>
                <td align="center">36</td>
                <td align="center">Pure- UHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">17</td>
                <td align="center">C.1838A-&gt; C</td>
                <td align="center">p.Asp613Ala</td>
                <td align="center">This study</td>
              </tr>
              <tr>
                <td align="center" colspan="8">
                  <bold>EXON DELETIONS</bold>
                </td>
              </tr>
              <tr>
                <td align="center">199</td>
                <td align="center">20</td>
                <td align="center">Pure-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">-</td>
                <td/>
                <td align="center">EX10-16 deletion</td>
                <td align="center">[<xref ref-type="bibr" rid="B14">14</xref>]</td>
              </tr>
              <tr>
                <td align="center">225</td>
                <td align="center">14</td>
                <td align="center">Pure-ADHSP</td>
                <td align="center">
                  <italic>SPAST</italic>
                </td>
                <td align="center">-</td>
                <td/>
                <td align="center">Ex 6-7 deletion</td>
                <td align="center">This study</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p>* ADHSP- Autosomal dominant spastic paraplegia; SHSP: apparently sporadic spastic paraplegia (including siblings with healthy parents); UHSP: Unkown familial history spastic paraplegia</p>
          </table-wrap-foot>
        </table-wrap>
        <fig id="F1" position="float">
          <label>Figure 1</label>
          <caption>
            <p><bold>Schematic diagram of <italic>SPAST </italic>and <italic>ATL1 </italic>domains showing the location of the mutations</bold>. The one letter code was used to identify the amino acid changes. Novel mutations are in bold.</p>
          </caption>
          <graphic xlink:href="1471-2377-10-89-1"/>
        </fig>
      </sec>
      <sec>
        <title><italic>SPAST </italic>missense mutations out of the AAA domain</title>
        <p>Most of the missense mutations were in the AAA domain. Two novel missense changes (p. Pro293Leu, and p. Asp613Ala) were outside of the AAA domain, where missense mutations have been rarely found. The two amino acids were evolutionary conserved. The p.Pro293Leu proband was a 51-year-old man with progressive gait disorder starting at the age of 31, who has been confined to a wheelchair due to his spasticity (pure form) for the last two years. His 46-year-old sister, and one of his daughters (18 years old) also carried this mutation. They both presented brisk reflexes and Babinski's sign, but no spasticity and an almost normal gait. The p.Asp613Ala was found in a 45 years old man with a pure phenotype affecting only the lower limbs and the first symptoms at the age of 36 years. He did not report a family history of the disease, although no relatives were studied.</p>
        <p>We also found a new <italic>SPAST </italic>missense variant (p.Ile328Leu) in a 15 years old male with complicated spastic paraplegia starting at the age of 18 months. This putative mutation was also found in his father's grandmother (asymptomatic), but the proband's father was not available for study. Although this variant was not found among the controls and involved a conserved amino acid, a bioinformatics analysis (SIFT v2. program, Sorting Intolerant From Tolerant; <ext-link ext-link-type="uri" xlink:href="http://sift.jcvi.org/">http://sift.jcvi.org/</ext-link>) indicated a non significant change in the protein function, and was thus classified as a change of uncertain pathogenic effect.</p>
      </sec>
      <sec>
        <title><italic>SPAST </italic>c.583C&gt;G (exon 3) affected splicing</title>
        <p>The c.583C&gt;G (p.Leu195Val) was found in a 19 years old male with an onset at the age of 2 years and a phenotype complicated with neuropathy. He was from a family with ADSPH in which we confirmed the segregation of the disease with this mutation. This has been previously reported as a missense mutation, and the bioinformatic analysis (SIFT v2. program) indicated that this change would affect the protein function. However, the c.583C&gt;G was four nucleotides from the 3' end of exon 3, and was also predicted to reduce the score of the splicing consensus site (Human Splicing Finder v. 2.4; <ext-link ext-link-type="uri" xlink:href="http://www.umd.be/SSF">http://www.umd.be/SSF</ext-link>). This mutation could thus result in an aberrant mRNA sequence. To confirm this, we isolated the mRNA from the patient's blood leukocytes and amplified the <italic>SPAST </italic>cDNA with primers for exons 2 and 7. The last 4 nucleotides of exon 3 were missed in the transcript, that would thus be translated into an aberrant protein (Figure <xref ref-type="fig" rid="F2">2A</xref>).</p>
        <fig id="F2" position="float">
          <label>Figure 2</label>
          <caption>
            <p><bold>A) The cDNA from patient 138 (carrier of c.583C&gt;G in exon 3 of <italic>SPAST</italic>) was synthesised from leukocytes mRNA</bold>. The sequencing of the fragment amplified with primers that matched exons 2 and 7 showed the deletion of the last 4 nucleotides of exon 3. <bold>B) </bold>The cDNA from patient 212 (X617Glu) was amplified with primers for exons 11 and 17 of <italic>SPAST</italic>, and the sequence showed similar electropherogram peaks for the two alleles. <bold>C) </bold>The cDNA of patient 322 was amplified with primers for exons 7 and 17 of <italic>SPAST</italic>, and the sequence showed the effect on splicing of the c.1414-1G&gt;C mutation. <bold>D) </bold>MLPA of the <italic>SPAST </italic>gene in patient 199, showing the exons 10-16 deletion. The cDNA was amplified with primers that matched exons 9 and 17, and two PCR fragments were obtained. Sequencing of the smaller fragment confirmed the absence of exons 10 to 16. P = patient (cDNA); M = Patient's mother's (cDNA); C = Control (cDNA); G = Genomic DNA</p>
          </caption>
          <graphic xlink:href="1471-2377-10-89-2"/>
        </fig>
      </sec>
      <sec>
        <title><italic>SPAST </italic>sense mutation</title>
        <p>We found a novel mutation in the <italic>SPAST </italic>stop codon, c.1849T&gt;G (p.X617Glu) in two non related patients without known affected relatives. The mutated transcript was predicted to be translated into a 46 amino acids longer protein. To determine the stability of the mRNA containing this mutation, we synthesized the cDNA from RNA obtained from leukocytes of one of the patients and amplified and sequenced a PCR-fragment generated with primers that matched exons 11 and the 3' untranslated region (UTR). The two alleles gave equally intense sequence electropherogram peaks, suggesting that c.1849G did not increase the mRNA decay and was likely translated into a mutated protein (Figure <xref ref-type="fig" rid="F2">2B</xref>).</p>
      </sec>
      <sec>
        <title><italic>SPAST </italic>mutations affecting splicing</title>
        <p>In addition to the above described c.583C&gt;G in exon 3 of <italic>SPAST</italic>, we found five changes in intron splicing consensus nucleotides. The <italic>in silico </italic>analysis (Splice Site Prediction by Neural Network; <ext-link ext-link-type="uri" xlink:href="http://www.fruitfly.org/seq_tools/splice.html">http://www.fruitfly.org/seq_tools/splice.html</ext-link>) indicated that the five changes would affect the pre-mRNA splicing. We could synthesize the cDNA from four of the patients, that was amplified with primers that matched exons 7 and 17, and exons 11 and 17. In all these cases two PCR-fragments were amplified, and the longer fragment corresponded to the wild type transcript while the shorter resulted from an exon skipping. In this way, we confirmed the existence of defective transcripts (Figure <xref ref-type="fig" rid="F2">2C</xref>).</p>
      </sec>
      <sec>
        <title>Large <italic>SPAST </italic>deletions</title>
        <p>We performed MLPA analysis in the 77 ADHSP cases who were negative for <italic>ATL1 </italic>and <italic>SPAST </italic>sequencing mutations. Two patients (2.5%) showed a significantly reduced amplification signal for exons 10-16, or exons 6-7 of <italic>SPAST</italic>. In the patient with a putative deletion of exons 10-16 we amplified the cDNA with primers that matched exons 9 and 17, and confirmed the skipping of exons 10-16 (Figure <xref ref-type="fig" rid="F2">2D</xref>). In this pedigree, the age at onset (third decade) was similar in the three affected members who were studied, and the oldest patient (an 81-year-old man) had been confined to a wheelchair for the previous five years.</p>
      </sec>
      <sec>
        <title><italic>ATL1 </italic>mutations</title>
        <p>The <italic>ATL1 </italic>exons were sequenced in a total 88 patients with ADHSP and in 99 patients without a family history of HSP and an onset age â¤20 years. We found seven mutations and a variant with uncertain pathogenic effect in 11 patients (Table <xref ref-type="table" rid="T2">2</xref>). Three were novel missense changes (p.His256Asp, p.Gln154Glu, and p.Phe413Val), while 5 had been reported. The p.Arg239Cys was a recurrent mutation found in 3 non related patients.</p>
        <table-wrap id="T2" position="float">
          <label>Table 2</label>
          <caption>
            <p>Mutations in the <italic>ATL1 </italic>gene.</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th align="left">Case</th>
                <th align="left">onset age (Years)</th>
                <th align="left">Phenotype/Inheritance</th>
                <th align="left">GEN</th>
                <th align="left">Exon</th>
                <th align="left">Mutation</th>
                <th align="left">Protein</th>
                <th align="left">Reference</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">57.1</td>
                <td align="left">1</td>
                <td align="left">Pure- SHSP</td>
                <td align="left">
                  <italic>ATL1</italic>
                </td>
                <td align="left">4</td>
                <td align="left">c.460 C&gt;G</td>
                <td align="left">p.Gln154Glu</td>
                <td align="left">This study</td>
              </tr>
              <tr>
                <td align="left">97</td>
                <td align="left">8</td>
                <td align="left">Pure-ADHSP</td>
                <td align="left">
                  <italic>ATL1</italic>
                </td>
                <td align="left">7</td>
                <td align="left">c.715C&gt;T</td>
                <td align="left">p.Arg239Cys</td>
                <td align="left">[<xref ref-type="bibr" rid="B47">47</xref>]</td>
              </tr>
              <tr>
                <td align="left">102</td>
                <td align="left">4</td>
                <td align="left">Pure-ADHSP</td>
                <td align="left">
                  <italic>ATL1</italic>
                </td>
                <td align="left">7</td>
                <td align="left">c.715C&gt;T</td>
                <td align="left">p.Arg239Cys</td>
                <td align="left">[<xref ref-type="bibr" rid="B47">47</xref>]</td>
              </tr>
              <tr>
                <td align="left">220</td>
                <td align="left">3</td>
                <td align="left">Pure-ADHSP</td>
                <td align="left">
                  <italic>ATL1</italic>
                </td>
                <td align="left">7</td>
                <td align="left">c.715C&gt;T</td>
                <td align="left">p.Arg239Cys</td>
                <td align="left">[<xref ref-type="bibr" rid="B47">47</xref>]</td>
              </tr>
              <tr>
                <td align="left">279</td>
                <td align="left">5</td>
                <td align="left">Pure-ADHSP</td>
                <td align="left">
                  <italic>ATL1</italic>
                </td>
                <td align="left">7</td>
                <td align="left">c.715C&gt;T</td>
                <td align="left">p.Arg239Cys</td>
                <td align="left">[<xref ref-type="bibr" rid="B47">47</xref>]</td>
              </tr>
              <tr>
                <td align="left">64</td>
                <td align="left">10</td>
                <td align="left">Pure-ADHSP</td>
                <td align="left">
                  <italic>ATL1</italic>
                </td>
                <td align="left">8</td>
                <td align="left">c.757 G&gt;A</td>
                <td align="left">p.Val253Ile</td>
                <td align="left">[<xref ref-type="bibr" rid="B25">25</xref>]</td>
              </tr>
              <tr>
                <td align="left">159</td>
                <td align="left">5</td>
                <td align="left">Pure-ADHSP</td>
                <td align="left">
                  <italic>ATL1</italic>
                </td>
                <td align="left">12</td>
                <td align="left">c.1483c&gt;T</td>
                <td align="left">p.Arg495Trp</td>
                <td align="left">[<xref ref-type="bibr" rid="B25">25</xref>]</td>
              </tr>
              <tr>
                <td align="left">110</td>
                <td align="left">17</td>
                <td align="left">Pure-ADHSP</td>
                <td align="left">
                  <italic>ATL1</italic>
                </td>
                <td align="left">12</td>
                <td align="left">c.1319A-&gt;C</td>
                <td align="left">p.Asn440Thr</td>
                <td align="left">[<xref ref-type="bibr" rid="B25">25</xref>]</td>
              </tr>
              <tr>
                <td align="left">232</td>
                <td align="left">6</td>
                <td align="left">Pure-ADHSP</td>
                <td align="left">
                  <italic>ATL1</italic>
                </td>
                <td align="left">12</td>
                <td align="left">c.1237T-&gt;G</td>
                <td align="left">p.Phe413Val</td>
                <td align="left">This study</td>
              </tr>
              <tr>
                <td align="left">233</td>
                <td align="left">16</td>
                <td align="left">Complicated-ADHSP</td>
                <td align="left">
                  <italic>ATL1</italic>
                </td>
                <td align="left">12</td>
                <td align="left">c.1243 C-&gt;T</td>
                <td align="left">p.Arg415Trp</td>
                <td align="left">[<xref ref-type="bibr" rid="B40">40</xref>]</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>Mutations p.Gln154Glu, (c.460 C&gt;G), p. His256Asp (c.766C&gt;A), and p.Phe413Val (c.1237T&gt;G) are located in the guanilate binding protein domains. The p.Gln154Glu mutation was found in a patient with a pure phenotype and onset of symptoms in childhood. His son showed gait problems at the age of two years. The p.His256Asp patient was a 45 years old woman with the onset of symptoms at the age of 3 years and a progressive spastic paraplegia (Additional file <xref ref-type="supplementary-material" rid="S2">2</xref>, Figure S1). In her family, we identified mutation carriers who were asymptomatic at ages of 60 and 63 years, and this could thus be classified as a variant with uncertain pathogenic effect. Mutation p.Phe413Val was found in a patient with an onset age of 6 years and a complicated phenotype (neuropathy). Her mother was affected, but she was death and we could not confirm whether carried the mutation. None of the 77 ADHSP patients studied through MLPA showed evidence for large <italic>ATL1 </italic>deletions.</p>
      </sec>
      <sec>
        <title><italic>SPAST </italic>and <italic>ATL1 </italic>polymorphisms</title>
        <p>We found several polymorphisms in the two genes (Additional file <xref ref-type="supplementary-material" rid="S1">1</xref>, Table S3). All the new polymorphisms were intronic, or exonic silent amino acid changes with one exception: c.844 T&gt;A in exon 5 of <italic>SPAST </italic>(p.Ser282Thr). This missense change affected an amino conserved between species and was not found in any of the 400 controls. Although it could be considered a putative mutation, was in a patient with the p.Ser261X mutation (located also in exon 5). Segregation analysis to determine whether the two nucleotide changes were in different chromosomes was not possible. However, the electrophoretic pattern of bands after double restriction enzyme digestion (<italic>MnlI </italic>+ <italic>MboI</italic>) of the exon 5 fragment indicated that the mutation was <italic>in cis </italic>with the c.844 A allele (data not shown). This suggested that this was likely a rare variant, rather than an HSP mutation. Two missense polymorphisms that have been proposed as modifiers of the clinical phenotype (p.Ser44Leu and p.Pro45Leu) were not found in our patients [<xref ref-type="bibr" rid="B29">29</xref>].</p>
      </sec>
      <sec>
        <title>Genotype-phenotype correlation</title>
        <p>The phenotype associated with <italic>SPAST </italic>and <italic>ATL1 </italic>mutations was pure in 48 (87%) and 10 (90%) of the index patients, respectively. We analysed all the available relatives of the 63 index cases with mutations, and identified a total of 54 <italic>SPAST </italic>and 15 <italic>ATL1 </italic>mutation carriers. A total of 13 mutation carriers (10 for <italic>SPAST </italic>and 3 for <italic>ATL1 </italic>gene) were asymptomatic at the time of our analysis. The mean onset age of the disease (index cases and relatives) was 34.5 (Â± 17.72) years for <italic>SPAST </italic>mutation carriers, and 7.67 (Â± 5.9 years) for <italic>ATL1 </italic>mutation carriers (p &lt; 0.001). A difference was also observed between <italic>ATL1 </italic>mutation carriers and patients without <italic>SPAST/ATL1 </italic>mutations (7.67 Â± 5.9 vs. 27.78 Â± 20.238; p &lt; 0.001). The mean duration of symptoms at the time of examination did not differ between patients with <italic>SPAST </italic>(14.5 Â± 11.1) and <italic>ATL1 </italic>(18.78 Â± 15.057) mutations. No difference in disease duration was observed between <italic>SPAST </italic>or <italic>ATL1 </italic>mutation carriers and patients without mutations.</p>
      </sec>
    </sec>
    <sec>
      <title>Discussion</title>
      <p><italic>SPAST </italic>mutations (including large gene deletions) were found in 15% (54/370) of the patients, but this frequency increased to 31% (44/141) among patients with ADHSP. Most of the <italic>SPAST </italic>mutations were novel, and this was in agreement with previous reports that described a high rate of private mutations in this gene [<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B15">15</xref>]. We found an <italic>ATL1 </italic>mutation in 6% of the patients studied for this gene, but this frequency could be underestimated because we did not include ADHSP patients with a <italic>SPAST </italic>mutation or patients with sporadic/uncertain HSP and an onset age &gt;20 years. However, we think that the <italic>ATL1 </italic>mutation rate should be right because double mutated patients (<italic>SPAST </italic>+ <italic>ATL1</italic>) have not been reported, and <italic>ATL1 </italic>mutations were rare among non-ADHSP patients with an onset age &gt;20 years [<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B26">26</xref>].</p>
      <p>Considering the ADHSP cases, the mutational screening of <italic>SPAST </italic>and <italic>ATL1 </italic>identified a total of 54 mutation carriers, a frequency (38%) within the range reported in other populations [<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B32">32</xref>]. Also in agreement with previous reports, the frequency of <italic>SPAST </italic>and <italic>ATL1 </italic>mutation carriers was much lower among patients with sporadic/uncertain HSP [<xref ref-type="bibr" rid="B12">12</xref>]. Four of the sporadic cases had a <italic>de novo </italic>mutation. A high rate of <italic>de novo </italic>mutational events for <italic>SPAST </italic>and <italic>ATL1 </italic>has been previously described, indicating that sporadic cases should also be screened for mutations in these genes after exclusion of other major neurological causes of spasticity [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B33">33</xref>-<xref ref-type="bibr" rid="B35">35</xref>].</p>
      <p><italic>SPAST </italic>mutations are mostly restricted to the AAA protein domain. It is thus remarkable that three of the missense mutations in our patients were out of this domain (p.Leu195Val, p.Pro293Leu, and p.Asp613Ala). In the case of <italic>ATL1 </italic>all the mutations were missense changes in the GTPase and transmembrane domains of atlastin, and would disrupt the normal protein folding and oligomerization [<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref>]. The <italic>SPAST </italic>c.C583G variant was previously reported as a missense mutation (p.Leu195Val) [<xref ref-type="bibr" rid="B10">10</xref>]. However, this change was within the consensus splicing sequence of exon 3 and we confirmed its effect on pre-RNA splicing. Nucleotide changes in the last nucleotides of exons could result in both, normal and splicing defective transcripts [<xref ref-type="bibr" rid="B36">36</xref>-<xref ref-type="bibr" rid="B38">38</xref>]. Although we found an aberrant transcript we could not define whether the c.583 G resulted also in normal transcripts.</p>
      <p>In the <italic>SPAST </italic>gene we also found one mutation in the stop codon (c.1849T&gt;G; X617Glu), that would result in the translation of 46 amino acid beyond the stop codon. To our knowledge, this is the first sense mutation reported in this gene. The abolishment of a stop codon and the appearance of a longer ORF has been found in other hereditary diseases, such as the British Familial Dementia caused by a sense mutation in the <italic>ITM2B </italic>gene [<xref ref-type="bibr" rid="B39">39</xref>].</p>
      <p>We performed MLPA analysis in 78 patients with ADHSP and we found two large deletions in the <italic>SPAST </italic>gene, which accounts for 2.5% of patients. In a recent work Shoukier et al. reported a similar frequency for this type of mutation [<xref ref-type="bibr" rid="B12">12</xref>]. However, previous studies reported a much higher frequency (18-23%) [<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B15">15</xref>]. Additional studies are thus necessary to define the frequency of large deletions/duplications in the aetiology of HSP.</p>
      <p>Finaly, <italic>SPAST </italic>and <italic>ATL1 </italic>mutations have been associated with variable penetrance, leading to heterogeneous HSP phenotypes in terms of onset age and clinical symptoms (pure vs. complicated) [<xref ref-type="bibr" rid="B40">40</xref>,<xref ref-type="bibr" rid="B15">15</xref>]. This heterogeneity could be partly explained by different mutated genes. As discussed above, we observed a significantly higher frequency of familial dominant HSP among <italic>ATL1 </italic>patients, compared to <italic>SPAST </italic>mutation carriers, and pure HSP was also more frequent among the patients with <italic>ATL1 </italic>mutations. However, phenotypic variability was also common among mutation carriers from the same family.</p>
    </sec>
    <sec>
      <title>Conclusions</title>
      <p>In conclusion, we reported the mutational spectrum of the <italic>SPAST </italic>and <italic>ATL1 </italic>genes in a large cohort of Spanish patients with spastic paraplegia. We found a mutation in 15% of the cases, and a frequency of mutation carriers significantly higher among ADHSP compared to sporadic cases. Thus, the genetic screening should be more relevant in patients (pure and complicated phenotypes) with a family history of the disease. However, the fact that a significant number of apparently sporadic cases had a mutation suggested that these patients should not be excluded from the genetic study. The mutational report could be of limited value to predict the phenotype associated to these mutations, as demonstrated by the heterogeneous behavior of most of the mutations.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The authors declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors' contributions</title>
      <p>All the authors contributed to this work by recruiting the patients, obtaining the clinical and analytical information, or performing the laboratory work. VA designated the work and analyzed the results. VA, ES-F, CB, M., BA, and AIC performed all the genetic analysis. VA and EC wrote the manuscript. All authors have read and approved the submission of this manuscript.</p>
    </sec>
    <sec>
      <title>Note</title>
      <p>* Manuel AmorÃ­n, Eugenia Marzo-Sola, Carlos H. Lahoz, Pia Gallano, ConcepciÃ³n Alonso-Cerezo, Rafael Palencia-Luaces, Eduardo GutiÃ©rrez- Rivas, Rogelio SimÃ³n, Loreto Martorell, Eduardo LÃ³pez-Laso, JosÃ© M. Asensi, Luis HernÃ¡ndez- Echebarria, Yolanda Morgado, Alonso GonzÃ¡lez-Masegosa, Juan J. Garcia- PeÃ±as, Irene Catalina-Alvarez, JosÃ© L. MuÃ±oz-Blanco, Miguel FernÃ¡ndez-Burriel, Juan B. Espinal, Mariano Aparicio- Blanco, Jon Infante, MarÃ­a VÃ¡zquez-Espinar, Elena Maside</p>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2377/10/89/prepub">http://www.biomedcentral.com/1471-2377/10/89/prepub</ext-link>
      </p>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supplementary Material</title>
      <supplementary-material content-type="local-data" id="S1">
        <caption>
          <title>Additional file 1</title>
          <p><bold>Supplementary tables and supplementary figure 1 legendl for Alvarez et al</bold>. This file contains information about PCR primers, polymorphisms detected and legend of supplementary figure.</p>
        </caption>
        <media xlink:href="1471-2377-10-89-S1.DOC" mimetype="application" mime-subtype="msword">
          <caption>
            <p>Click here for file</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="S2">
        <caption>
          <title>Additional file 2</title>
          <p><bold>supplementary FIGURE1 for Alvarez et al</bold>. This file contains a figure showing several examples of mutations detected.</p>
        </caption>
        <media xlink:href="1471-2377-10-89-S2.JPEG" mimetype="image" mime-subtype="jpeg">
          <caption>
            <p>Click here for file</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <sec>
      <title>Acknowledgements</title>
      <p>This work was supported by grants from Spanish Fondo de Investigaciones Sanitarias PI08/0915 (European FEDER founds) to V.A. E.S-F. was a fellowship from FICYT-Principado de Asturias. The authors thank the patients and family members for their participation in this study. Authors wish to thank FundaciÃ³n Parkinson Asturias and Obra Social CAJASTUR for their support.</p>
    </sec>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Harding</surname>
            <given-names>AE</given-names>
          </name>
          <article-title>Classification of the hereditary ataxias and paraplegias</article-title>
          <source>Lancet</source>
          <year>1983</year>
          <volume>1</volume>
          <fpage>1151</fpage>
          <lpage>1155</lpage>
          <pub-id pub-id-type="doi">10.1016/S0140-6736(83)92879-9</pub-id>
          <pub-id pub-id-type="pmid">6133167</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Stevanin</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Ruberg</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Brice</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Recent advances in the genetics of spastic paraplegias</article-title>
          <source>Curr Neurol Neurosci Rep</source>
          <year>2008</year>
          <volume>8</volume>
          <fpage>198</fpage>
          <lpage>210</lpage>
          <pub-id pub-id-type="doi">10.1007/s11910-008-0032-z</pub-id>
          <pub-id pub-id-type="pmid">18541115</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Salinas</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Proukakis</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Crosby</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Warner</surname>
            <given-names>TT</given-names>
          </name>
          <article-title>Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms</article-title>
          <source>Lancet Neurol</source>
          <year>2008</year>
          <volume>7</volume>
          <fpage>1127</fpage>
          <lpage>38</lpage>
          <pub-id pub-id-type="doi">10.1016/S1474-4422(08)70258-8</pub-id>
          <pub-id pub-id-type="pmid">19007737</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Dursun</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Koroglu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Kocasoy Orhan</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Ugur</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>Tolun</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Autosomal recessive spastic paraplegia (SPG45) with mental retardation maps to10q24.3-q25.1</article-title>
          <source>Neurogenetics</source>
          <year>2009</year>
          <volume>10</volume>
          <fpage>325</fpage>
          <lpage>31</lpage>
          <pub-id pub-id-type="doi">10.1007/s10048-009-0191-3</pub-id>
          <pub-id pub-id-type="pmid">19415352</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Errico</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ballabio</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Rugarli</surname>
            <given-names>EI</given-names>
          </name>
          <article-title>Spastin, the protein mutated in autosomal dominant hereditary spastic paraplegia, is involved in microtubule dynamics</article-title>
          <source>Hum Mol Genet</source>
          <year>2002</year>
          <volume>11</volume>
          <fpage>153</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="doi">10.1093/hmg/11.2.153</pub-id>
          <pub-id pub-id-type="pmid">11809724</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Park</surname>
            <given-names>SH</given-names>
          </name>
          <name>
            <surname>Zhu</surname>
            <given-names>PP</given-names>
          </name>
          <name>
            <surname>Parker</surname>
            <given-names>RL</given-names>
          </name>
          <name>
            <surname>Blackstone</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Hereditary spastic paraplegia proteins REEP1, spastin, and atlastin-1 coordinate microtubule interactions with the tubular ER network</article-title>
          <source>J Clin Invest</source>
          <year>2010</year>
          <volume>120</volume>
          <fpage>1097</fpage>
          <lpage>110</lpage>
          <pub-id pub-id-type="doi">10.1172/JCI40979</pub-id>
          <pub-id pub-id-type="pmid">20200447</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Fonknechten</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Mavel</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Byrne</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Davoine</surname>
            <given-names>CS</given-names>
          </name>
          <name>
            <surname>Cruaud</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>BÃ¶nsch</surname>
            <given-names>D</given-names>
          </name>
          <etal/>
          <article-title>Spectrum of SPG4 mutations in autosomal dominant spasticparaplegia</article-title>
          <source>Hum Mol Genet</source>
          <year>2000</year>
          <volume>9</volume>
          <fpage>637</fpage>
          <lpage>44</lpage>
          <pub-id pub-id-type="doi">10.1093/hmg/9.4.637</pub-id>
          <pub-id pub-id-type="pmid">10699187</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Sauter</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Miterski</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Klimpe</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>BÃ¶nsch</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>SchÃ¶ls</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Visbeck</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
          <article-title>Mutation analysis of the spastin gene (SPG4) in patients in Germany with autosomal dominant hereditary spastic paraplegia</article-title>
          <source>Hum Mutat</source>
          <year>2002</year>
          <volume>20</volume>
          <fpage>127</fpage>
          <lpage>32</lpage>
          <pub-id pub-id-type="doi">10.1002/humu.10105</pub-id>
          <pub-id pub-id-type="pmid">12124993</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Patrono</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Scarano</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Cricchi</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Melone</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Chiriaco</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Napolitano</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
          <article-title>Autosomal dominant hereditary spastic paraplegia:DHPLC-based mutation analysis of SPG4 reveals eleven novel mutations</article-title>
          <source>Hum Mutat</source>
          <year>2005</year>
          <volume>25</volume>
          <fpage>506</fpage>
          <pub-id pub-id-type="doi">10.1002/humu.9340</pub-id>
          <pub-id pub-id-type="pmid">15841487</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Crippa</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Panzeri</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Martinuzzi</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Arnoldi</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Redaelli</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Tonelli</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
          <article-title>Eight novel mutations in SPG4 in a large sample of patients with hereditary spastic paraplegia</article-title>
          <source>ArchNeurol</source>
          <year>2006</year>
          <volume>63</volume>
          <fpage>750</fpage>
          <lpage>5</lpage>
        </mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Depienne</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Tallaksen</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Lephay</surname>
            <given-names>JY</given-names>
          </name>
          <name>
            <surname>Bricka</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Poea-Guyon</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Fontaine</surname>
            <given-names>B</given-names>
          </name>
          <etal/>
          <article-title>Spastin mutations are frequent in sporadic spastic paraparesis and their spectrum is different from that observed in familial cases</article-title>
          <source>J Med Genet</source>
          <year>2006</year>
          <volume>43</volume>
          <fpage>259</fpage>
          <lpage>65</lpage>
          <pub-id pub-id-type="doi">10.1136/jmg.2005.035311</pub-id>
          <pub-id pub-id-type="pmid">16055926</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Shoukier</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Neesen</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Sauter</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Argyriou</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Doerwald</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Pantakani</surname>
            <given-names>DV</given-names>
          </name>
          <etal/>
          <article-title>Expansion of mutation spectrum, determination of mutation cluster regions and predictive structural classification of SPAST mutations in hereditary spastic paraplegia</article-title>
          <source>Eur J Hum Genet</source>
          <year>2009</year>
          <volume>17</volume>
          <fpage>187</fpage>
          <lpage>94</lpage>
          <pub-id pub-id-type="doi">10.1038/ejhg.2008.147</pub-id>
          <pub-id pub-id-type="pmid">18701882</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Beetz</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Nygren</surname>
            <given-names>AO</given-names>
          </name>
          <name>
            <surname>Schickel</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Auer-Grumbach</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>BÃ¼rk</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Heide</surname>
            <given-names>G</given-names>
          </name>
          <etal/>
          <article-title>High frequency of partial SPAST deletions in autosomal dominant hereditary spastic paraplegia</article-title>
          <source>Neurology</source>
          <year>2006</year>
          <volume>67</volume>
          <fpage>1926</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="doi">10.1212/01.wnl.0000244413.49258.f5</pub-id>
          <pub-id pub-id-type="pmid">17035675</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Depienne</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Fedirko</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Forlani</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Cazeneuve</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>RibaÃ¯</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Feki</surname>
            <given-names>I</given-names>
          </name>
          <etal/>
          <article-title>Exon deletions of SPG4 are a frequent cause of hereditary spastic paraplegia</article-title>
          <source>J Med Genet</source>
          <year>2007</year>
          <volume>44</volume>
          <fpage>281</fpage>
          <lpage>284</lpage>
          <pub-id pub-id-type="doi">10.1136/jmg.2006.046425</pub-id>
          <pub-id pub-id-type="pmid">17098887</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Erichsen</surname>
            <given-names>AK</given-names>
          </name>
          <name>
            <surname>Inderhaug</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Mattingsdal</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Eiklid</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Tallaksen</surname>
            <given-names>CM</given-names>
          </name>
          <article-title>Seven novelmutations and four exon deletions in a collection of Norwegian patients with SPG4 hereditary spastic paraplegia</article-title>
          <source>Eur J Neurol</source>
          <year>2007</year>
          <volume>14</volume>
          <fpage>809</fpage>
          <lpage>14</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1468-1331.2007.01861.x</pub-id>
          <pub-id pub-id-type="pmid">17594340</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Mitne-Neto</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kok</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Beetz</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Pessoa</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Bueno</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Graciani</surname>
            <given-names>Z</given-names>
          </name>
          <etal/>
          <article-title>A multi-exonic SPG4 duplication underlies sex-dependent penetrance of hereditary spastic paraplegia in a large Brazilian pedigree</article-title>
          <source>Eur J Hum Genet</source>
          <year>2007</year>
          <volume>15</volume>
          <fpage>1276</fpage>
          <lpage>1279</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.ejhg.5201924</pub-id>
          <pub-id pub-id-type="pmid">17895902</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Patrono</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Casali</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Tessa</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Cricchi</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Fortini</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Carrozzo</surname>
            <given-names>R</given-names>
          </name>
          <etal/>
          <article-title>Missense and splice site mutations in SPG4 suggest loss-of-function in dominant spastic paraplegia</article-title>
          <source>J Neurol</source>
          <year>2002</year>
          <volume>249</volume>
          <fpage>200</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="doi">10.1007/PL00007865</pub-id>
          <pub-id pub-id-type="pmid">11985387</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Charvin</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Cifuentes-Diaz</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Fonknechten</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Joshi</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Hazan</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Melki</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
          <article-title>Mutations of SPG4 are responsible for a loss of function of spastin, an abundant neuronal protein localized in the nucleus</article-title>
          <source>Hum Mol Genet</source>
          <year>2003</year>
          <volume>12</volume>
          <fpage>71</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1093/hmg/ddg004</pub-id>
          <pub-id pub-id-type="pmid">12490534</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Solowska</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Garbern</surname>
            <given-names>JY</given-names>
          </name>
          <name>
            <surname>Baas</surname>
            <given-names>PW</given-names>
          </name>
          <article-title>Evalution of loss of function as an explanation for SPG4-based hereditary spastic paraplegia</article-title>
          <source>Hum Mol Genet</source>
          <year>2010</year>
          <volume>19</volume>
          <fpage>1</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="doi">10.1093/hmg/ddq177</pub-id>
          <pub-id pub-id-type="pmid">19797313</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Namekawa</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Muriel</surname>
            <given-names>MP</given-names>
          </name>
          <name>
            <surname>Janer</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Latouche</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Dauphin</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Debeir</surname>
            <given-names>T</given-names>
          </name>
          <etal/>
          <article-title>Mutations in the SPG3A gene encoding the GTPase atlastin interfere with vesicle trafficking in the ER/Golgi interface and Golgi morphogenesis</article-title>
          <source>Mol Cell Neurosci</source>
          <year>2007</year>
          <volume>35</volume>
          <fpage>1</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="doi">10.1016/j.mcn.2007.01.012</pub-id>
          <pub-id pub-id-type="pmid">17321752</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Muriel</surname>
            <given-names>MP</given-names>
          </name>
          <name>
            <surname>Dauphin</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Namekawa</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Gervais</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Brice</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ruberg</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Atlastin-1, the dynamin-like GTPase responsible for spastic paraplegia SPG3A, remodels lipid membranes and may form tubules and vesicles in the endoplasmic reticulum</article-title>
          <source>J Neurochem</source>
          <year>2009</year>
          <volume>110</volume>
          <fpage>1607</fpage>
          <lpage>1616</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1471-4159.2009.06258.x</pub-id>
          <pub-id pub-id-type="pmid">19573020</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Sauter</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Engel</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Neumann</surname>
            <given-names>LM</given-names>
          </name>
          <name>
            <surname>Kunze</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Neesen</surname>
          </name>
          <article-title>Novel mutations in the Atlastin gene (SPG3A) in families with autosomal dominant hereditary spastic paraplegia and evidence for late onset forms of HSP linked to the SPG3A locus</article-title>
          <source>Hum Mutat</source>
          <year>2004</year>
          <volume>23</volume>
          <fpage>98</fpage>
          <pub-id pub-id-type="doi">10.1002/humu.9205</pub-id>
          <pub-id pub-id-type="pmid">14695538</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Ivanova</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Claeys</surname>
            <given-names>KG</given-names>
          </name>
          <name>
            <surname>Deconinck</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Litvinenko</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Jordanova</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Auer-Grumbach</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
          <article-title>Hereditary spastic paraplegia 3A associated with axonal neuropathy</article-title>
          <source>Arch Neurol</source>
          <year>2007</year>
          <volume>64</volume>
          <fpage>706</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="doi">10.1001/archneur.64.5.706</pub-id>
          <pub-id pub-id-type="pmid">17502470</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Abel</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Fonknechten</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Hofer</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>DÃ¼rr</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Cruaud</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Voit</surname>
            <given-names>T</given-names>
          </name>
          <etal/>
          <article-title>Early onset autosomal dominant spastic paraplegia caused by novel mutations in SPG3A</article-title>
          <source>Neurogenetics</source>
          <year>2004</year>
          <volume>5</volume>
          <fpage>239</fpage>
          <lpage>43</lpage>
          <pub-id pub-id-type="doi">10.1007/s10048-004-0191-2</pub-id>
          <pub-id pub-id-type="pmid">15517445</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation publication-type="journal">
          <name>
            <surname>DÃ¼rr</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Camuzat</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Colin</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Tallaksen</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Hannequin</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Coutinho</surname>
            <given-names>P</given-names>
          </name>
          <etal/>
          <article-title>Atlastin1 mutations are frequent in young-onset autosomal dominant spastic paraplegia</article-title>
          <source>Arch Neurol</source>
          <year>2004</year>
          <volume>61</volume>
          <fpage>1867</fpage>
          <lpage>72</lpage>
          <pub-id pub-id-type="doi">10.1001/archneur.61.12.1867</pub-id>
          <pub-id pub-id-type="pmid">15596607</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B26">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Namekawa</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ribai</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Nelson</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Forlani</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Fellmann</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Goizet</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
          <article-title>SPG3A is the most frequent cause of hereditary spastic paraplegia with onset before age 10 years</article-title>
          <source>Neurology</source>
          <year>2006</year>
          <volume>66</volume>
          <fpage>112</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="doi">10.1212/01.wnl.0000191390.20564.8e</pub-id>
          <pub-id pub-id-type="pmid">16401858</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B27">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Tallaksen</surname>
            <given-names>CM</given-names>
          </name>
          <name>
            <surname>DÃ¼rr</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Brice</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Recent advances in hereditary spastic paraplegia</article-title>
          <source>Curr Opin Neurol</source>
          <year>2001</year>
          <volume>14</volume>
          <fpage>457</fpage>
          <lpage>463</lpage>
          <pub-id pub-id-type="doi">10.1097/00019052-200108000-00005</pub-id>
          <pub-id pub-id-type="pmid">11470961</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B28">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Randall</surname>
            <given-names>LP</given-names>
          </name>
          <name>
            <surname>Coldham</surname>
            <given-names>NG</given-names>
          </name>
          <name>
            <surname>Woodward</surname>
            <given-names>MJ</given-names>
          </name>
          <article-title>Detection of mutations in Salmonella enterica gyrA, gyrB, parC and parE genes by denaturing high performance liquid chromatography (DHPLC) using standard HPLC instrumentation</article-title>
          <source>J Antimicrob Chemother</source>
          <year>2005</year>
          <volume>56</volume>
          <fpage>619</fpage>
          <lpage>23</lpage>
          <pub-id pub-id-type="doi">10.1093/jac/dki293</pub-id>
          <pub-id pub-id-type="pmid">16141278</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B29">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Svenson</surname>
            <given-names>IK</given-names>
          </name>
          <name>
            <surname>Kloos</surname>
            <given-names>MT</given-names>
          </name>
          <name>
            <surname>Gaskell</surname>
            <given-names>PC</given-names>
          </name>
          <name>
            <surname>Nance</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Garbern</surname>
            <given-names>JY</given-names>
          </name>
          <name>
            <surname>Hisanaga</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
          <article-title>Intragenic modifiers of hereditary spastic paraplegia due to spastin gene mutations</article-title>
          <source>Neurogenetics</source>
          <year>2004</year>
          <volume>5</volume>
          <fpage>157</fpage>
          <lpage>64</lpage>
          <pub-id pub-id-type="doi">10.1007/s10048-004-0186-z</pub-id>
          <pub-id pub-id-type="pmid">15248095</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B30">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Proukakis</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Auer-Grumbach</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Wagner</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Wilkinson</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Reid</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Patton</surname>
            <given-names>MA</given-names>
          </name>
          <etal/>
          <article-title>Screening of patients with hereditary spastic paraplegia reveals seven novel mutations in the SPG4 (Spastin) gene</article-title>
          <source>Hum Mutat</source>
          <year>2003</year>
          <volume>21</volume>
          <fpage>170</fpage>
          <pub-id pub-id-type="doi">10.1002/humu.9108</pub-id>
          <pub-id pub-id-type="pmid">12552568</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B31">
        <mixed-citation publication-type="journal">
          <name>
            <surname>McDermott</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Burness</surname>
            <given-names>CE</given-names>
          </name>
          <name>
            <surname>Kirby</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Cox</surname>
            <given-names>LE</given-names>
          </name>
          <name>
            <surname>Rao</surname>
            <given-names>DG</given-names>
          </name>
          <name>
            <surname>Hewamadduma</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
          <article-title>Clinical features of hereditary spastic paraplegia due to spastin mutation</article-title>
          <source>Neurology</source>
          <year>2006</year>
          <volume>67</volume>
          <fpage>45</fpage>
          <lpage>51</lpage>
          <pub-id pub-id-type="doi">10.1212/01.wnl.0000223315.62404.00</pub-id>
          <pub-id pub-id-type="pmid">16832076</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B32">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Loureiro</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Miller-Fleming</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Thieleke-Matos</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>MagalhÃ£es</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Cruz</surname>
            <given-names>VT</given-names>
          </name>
          <name>
            <surname>Coutinho</surname>
            <given-names>P</given-names>
          </name>
          <etal/>
          <article-title>Novel SPG3A and SPG4 mutations in dominant spastic paraplegia families</article-title>
          <source>Acta Neurol Scand</source>
          <year>2009</year>
          <volume>119</volume>
          <fpage>113</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1600-0404.2008.01074.x</pub-id>
          <pub-id pub-id-type="pmid">18664244</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B33">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Rainier</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Sher</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Reish</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Thomas</surname>
            <given-names>D</given-names>
          </name>
          <article-title>Fink JK De novo occurrence of novelSPG3A/atlastin mutation presenting as cerebral palsy</article-title>
          <source>Arch Neurol</source>
          <year>2006</year>
          <volume>63</volume>
          <fpage>445</fpage>
          <lpage>447</lpage>
          <pub-id pub-id-type="doi">10.1001/archneur.63.3.445</pub-id>
          <pub-id pub-id-type="pmid">16533974</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B34">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Scuderi</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Fichera</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Calabrese</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Elia</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Amato</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Savio</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Borgione</surname>
            <given-names>E</given-names>
          </name>
          <etal/>
          <article-title>Posterior fossa abnormalities in hereditary spastic paraparesis with spastin mutations</article-title>
          <source>J Neurol Neurosurg Psychiatry</source>
          <year>2009</year>
          <volume>80</volume>
          <fpage>440</fpage>
          <lpage>443</lpage>
          <pub-id pub-id-type="doi">10.1136/jnnp.2008.154807</pub-id>
          <pub-id pub-id-type="pmid">19289482</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B35">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Molon</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Montagna</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Angelini</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Pegoraro</surname>
            <given-names>E</given-names>
          </name>
          <article-title>Novel spastin mutations and their expression analysis in two Italian families</article-title>
          <source>Eur J Hum Genet</source>
          <year>2003</year>
          <volume>11</volume>
          <fpage>710</fpage>
          <lpage>713</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.ejhg.5201027</pub-id>
          <pub-id pub-id-type="pmid">12939659</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B36">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Svenson</surname>
            <given-names>IK</given-names>
          </name>
          <name>
            <surname>Ashley-Koch</surname>
            <given-names>AE</given-names>
          </name>
          <name>
            <surname>Gaskell</surname>
            <given-names>PC</given-names>
          </name>
          <name>
            <surname>Riney</surname>
            <given-names>TJ</given-names>
          </name>
          <name>
            <surname>Cumming</surname>
            <given-names>WJ</given-names>
          </name>
          <name>
            <surname>Kingston</surname>
            <given-names>HM</given-names>
          </name>
          <etal/>
          <article-title>Identification and expression analysis of spastin gene mutations in hereditary spastic paraplegia</article-title>
          <source>Am J Hum Genet</source>
          <year>2001</year>
          <volume>68</volume>
          <fpage>1077</fpage>
          <lpage>85</lpage>
          <pub-id pub-id-type="doi">10.1086/320111</pub-id>
          <pub-id pub-id-type="pmid">11309678</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B37">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Riveira-Munoz</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Chang</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Godefroid</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Hoenderop</surname>
            <given-names>JG</given-names>
          </name>
          <name>
            <surname>Bindels</surname>
            <given-names>RJ</given-names>
          </name>
          <name>
            <surname>Dahan</surname>
            <given-names>K</given-names>
          </name>
          <etal/>
          <article-title>Transcriptional and functional analyses of SLC12A3 mutations: new clues for the pathogenesis of Gitelman syndrome</article-title>
          <source>J Am Soc Nephrol</source>
          <year>2007</year>
          <volume>18</volume>
          <fpage>1271</fpage>
          <lpage>83</lpage>
          <pub-id pub-id-type="doi">10.1681/ASN.2006101095</pub-id>
          <pub-id pub-id-type="pmid">17329572</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B38">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Coto</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Arriba</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>GarcÃ­a-Castro</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Santos</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Corao</surname>
            <given-names>AI</given-names>
          </name>
          <name>
            <surname>DÃ­az</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
          <article-title>Clinical and analytical findings in Gitelman's syndrome associated with homozygosity for the c.1925 G&gt;A SLC12A3 mutation</article-title>
          <source>Am J Nephrol</source>
          <year>2009</year>
          <volume>30</volume>
          <fpage>218</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="doi">10.1159/000218104</pub-id>
          <pub-id pub-id-type="pmid">19420906</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B39">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Vidal</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Frangione</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Rostagno</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Mead</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>RÃ©vÃ©sz</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Plant</surname>
            <given-names>G</given-names>
          </name>
          <etal/>
          <article-title>A stop-codon mutation in the BRI gene associated with familial British dementia</article-title>
          <source>Nature</source>
          <year>1999</year>
          <volume>399</volume>
          <fpage>776</fpage>
          <lpage>81</lpage>
          <pub-id pub-id-type="doi">10.1038/21637</pub-id>
          <pub-id pub-id-type="pmid">10391242</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B40">
        <mixed-citation publication-type="journal">
          <name>
            <surname>D'Amico</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Tessa</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Sabino</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Bertini</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Santorelli</surname>
            <given-names>FM</given-names>
          </name>
          <name>
            <surname>Servidei</surname>
            <given-names>S</given-names>
          </name>
          <article-title>Incomplete penetrance in an SPG3A-linked family with a new mutation in the atlastin gene</article-title>
          <source>Neurology</source>
          <year>2004</year>
          <volume>62</volume>
          <fpage>2138</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">15184642</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B41">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Chinnery</surname>
            <given-names>PF</given-names>
          </name>
          <name>
            <surname>Keers</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Holden</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Ramesh</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Dalton</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Infantile hereditary spastic paraparesis due to codominant mutations in the spastin gene</article-title>
          <source>Neurology</source>
          <year>2004</year>
          <volume>63</volume>
          <fpage>710</fpage>
          <lpage>2</lpage>
          <pub-id pub-id-type="pmid">15326248</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B42">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Bertelli</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Cecchin</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Lorusso</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Sidoti</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Fabbri</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Lapucci</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
          <article-title>Identification of a novel mutation in the spastin gene (SPG4) in an Italian family with hereditary spastic paresis</article-title>
          <source>Panminerva Med</source>
          <year>2006</year>
          <volume>48</volume>
          <fpage>193</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">17122756</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B43">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Tang</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Xia</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Pan</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Luo</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Shen</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Long</surname>
            <given-names>Z</given-names>
          </name>
          <etal/>
          <article-title>Three novel mutations of the spastin gene in Chinese patients with hereditary spastic paraplegia</article-title>
          <source>Arch Neurol</source>
          <year>2004</year>
          <volume>61</volume>
          <fpage>49</fpage>
          <lpage>55</lpage>
          <pub-id pub-id-type="doi">10.1001/archneur.61.1.49</pub-id>
          <pub-id pub-id-type="pmid">14732620</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B44">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Park</surname>
            <given-names>SY</given-names>
          </name>
          <name>
            <surname>Ki</surname>
            <given-names>CS</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>HJ</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>JW</given-names>
          </name>
          <name>
            <surname>Sung</surname>
            <given-names>DH</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>BJ</given-names>
          </name>
          <etal/>
          <article-title>Mutation analysis of SPG4 and SPG3A genes and its implication in molecular diagnosis of Korean patients with hereditary spastic paraplegia</article-title>
          <source>Arch Neurol</source>
          <year>2005</year>
          <volume>62</volume>
          <fpage>1118</fpage>
          <lpage>1121</lpage>
          <pub-id pub-id-type="doi">10.1001/archneur.62.7.1118</pub-id>
          <pub-id pub-id-type="pmid">16009769</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B45">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Braschinsky</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Tamm</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Beetz</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Sachez-Ferrero</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Raukas</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>LÃ¼Ã¼s</surname>
            <given-names>SM</given-names>
          </name>
          <etal/>
          <article-title>Unique spectrum of SPAST variants in Estonian HSP patients: presence of benign missense changes but lack of exonic rearrangements</article-title>
          <source>BMC Neurol</source>
          <year>2010</year>
          <volume>10</volume>
          <fpage>17</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2377-10-17</pub-id>
          <pub-id pub-id-type="pmid">20214791</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B46">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Meijer</surname>
            <given-names>IA</given-names>
          </name>
          <name>
            <surname>Hand</surname>
            <given-names>CK</given-names>
          </name>
          <name>
            <surname>Cossette</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Figlewicz</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Rouleau</surname>
            <given-names>GA</given-names>
          </name>
          <article-title>Spectrum of SPG4 mutations in a large collection of North American families with hereditary spastic paraplegia</article-title>
          <source>Arch Neurol</source>
          <year>2002</year>
          <volume>59</volume>
          <fpage>281</fpage>
          <lpage>286</lpage>
          <pub-id pub-id-type="doi">10.1001/archneur.59.2.281</pub-id>
          <pub-id pub-id-type="pmid">11843700</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B47">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Wilkinson</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Hart</surname>
            <given-names>PE</given-names>
          </name>
          <name>
            <surname>Patel</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Warner</surname>
            <given-names>TT</given-names>
          </name>
          <name>
            <surname>Crosby</surname>
            <given-names>AH</given-names>
          </name>
          <article-title>SPG3A mutation screening in English families with early onset autosomal dominant hereditary spastic paraplegia</article-title>
          <source>J Neurol Sci</source>
          <year>2003</year>
          <volume>216</volume>
          <fpage>43</fpage>
          <lpage>45</lpage>
          <pub-id pub-id-type="doi">10.1016/S0022-510X(03)00210-7</pub-id>
          <pub-id pub-id-type="pmid">14607301</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>